Results from a randomized, double-blind, placebo-controlled, exploratory, multicenter study of GBR 830 in adult patients with moderate-to-severe atopic dermatitis
暂无分享,去创建一个
G. Gudi | G. Wolff | Ning Zhang | H. Wen | E. Guttman‐Yassky | A. Pavel | Y. Estrada | Hui Xu | Xiangyu Peng | Y. Salhi | F. Grossman | M. Pharm | H. Fang | S. Gn